Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.36%
1,096.72
+3.98
+0.36%
1,092.741,095.951,103.321,094.72
SIXC
Communications
SIXC
Communications
SIXC
-0.33%
611.32
-2.04
-0.33%
613.36613.36613.36609.50
SIXE
Energy
SIXE
Energy
SIXE
-0.45%
1,171.54
-5.25
-0.45%
1,176.791,176.521,182.251,166.69
SIXI
Industrials
SIXI
Industrials
SIXI
-0.45%
1,747.63
-7.91
-0.45%
1,755.541,759.231,766.301,746.04
SIXM
Financials
SIXM
Financials
SIXM
-0.58%
631.49
-3.66
-0.58%
635.15635.20636.89630.09
SIXR
Staples
SIXR
Staples
SIXR
+0.23%
849.94
+1.93
+0.23%
848.01852.52855.78849.58
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.09%
218.06
+0.20
+0.09%
217.86217.86219.52217.86
SIXT
Technology
SIXT
Technology
SIXT
+3.47%
3,536.03
+118.68
+3.47%
3,417.353,452.773,536.033,450.39
SIXU
Utilities
SIXU
Utilities
SIXU
-0.91%
905.07
-8.29
-0.91%
913.36915.10920.43904.57
SIXV
Health care
SIXV
Health care
SIXV
-0.86%
1,449.86
-12.52
-0.86%
1,462.381,461.131,464.531,446.02
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.30%
2,430.47
+7.33
+0.30%
2,423.142,428.712,448.692,424.63
300199:SHE
Hybio Pharmaceutical Co Ltd
CN¥20.44
-2.57%
(-0.54) 1D
May 8, 3:04:13 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300199...
Open
CN¥20.78
High
CN¥20.92
Low
CN¥20.40
Mkt. cap
18.53B
Avg. vol.
49.80M
Volume
36.94M
P/E ratio
191.01
52-wk high
CN¥31.19
52-wk low
CN¥13.46
EPS
CN¥0.11
Shares outstanding
883.24M
No. of employees
1K
News stories
From sources across the web
About Hybio Pharmaceutical Co Ltd
CEO-
Employees1.04K
Founded1998
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
239.47M
133.68M
283.23M
299.15M
Cost of goods sold
81.57M
64.65M
128.05M
105.01M
Cost of revenue
81.57M
64.65M
128.05M
105.01M
Research and development expenses
24.48M
27.93M
52.73M
30.87M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
40.23M
72.08M
63.79M
44.68M
Operating expense
66.61M
100.98M
96.24M
74.34M
Total operating expenses
148.17M
165.63M
224.29M
179.36M
Operating income
91.30M
-31.95M
58.94M
119.79M
Other non operating income
-3.50M
-8.30M
-113.30M
-29.77M
EBT including unusual items
83.61M
-72.35M
-23.38M
136.89M
EBT excluding unusual items
65.41M
-62.66M
16.93M
137.01M
Income tax expense
8.53M
2.41M
12.35M
9.50M
Effective tax rate
10.21%
-3.34%
-52.81%
6.94%
Other operating expenses
3.44M
3.09M
-20.10M
-1.21M
Net income
75.60M
-74.12M
-34.78M
127.81M
Net profit margin
31.57%
-55.44%
-12.28%
42.73%
Earnings per share
-
-
-
-
Interest and investment income
1.03M
2.00M
73.08M
-
Interest expense
-25.27M
-22.57M
-1.79M
-
Net interest expenses
-24.24M
-20.56M
71.29M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
124.10M
4.53M
91.92M
152.77M
Gain or loss from assets sale
-552.48K
552.48K
-617.19K
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more